Irbesartan

Back to search

Molecule Structure

Scientific Name

Irbesartan

Description of the Drug

Irbesartan is an angiotensin receptor blocker used to treat hypertension, delay progression of diabetic nephropathy, and treat congestive heart failure.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01029

Brand Name(s)

Aprovel, Avapro, Ifirmasta, Irbesartan, Karvea, Sabervel

Company Owner(s)

Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Picket Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Chartwell Molecular Holdings Llc, Teva Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Type-1 angiotensin II receptor SINGLE PROTEIN ANTAGONIST CHEMBL227

Unichem Links

SureChEMBL SCHEMBL4246
PharmGKB PA450084
Human Metabolome Database HMDB0015163
DrugBank DB01029
PubChem: Thomson Pharma 14758693 14905264
PubChem 3749
Mcule MCULE-9617953373
LINCS LSM-3338
Nikkaji J549.417F
BindingDB 50042235
EPA CompTox Dashboard DTXSID0023169
DrugCentral 1481
Brenda 196827
ChemicalBook CB4454663
Guide to Pharmacology 6908 589
rxnorm IRBESARTAN AVAPRO
PubChem: Drugs of the Future 12014641
KEGG Ligand C07469
ChEBI 5959
ZINC ZINC000003872931